Bryan Hubbard
September 10 2019

The most common—and the deadliest—cancers are not being researched by independent scientists, which is blocking the introduction of innovative, and non-chemo, therapies into mainstream treatment. Non-profit research funding is not being allocated to the research of these cancers—and it could be because some consider the cancers are 'embarrassing' or have been stigmatized.

Only breast cancer, leukemia, lymphoma and children's cancers are getting independent funding, say researchers at Northwestern University.

Read more: